NexGel Operating Expenses 2021-2024 | NXGL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

NexGel operating expenses from 2021 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

NexGel operating expenses from 2021 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$212.5B
Intuitive Surgical (ISRG)	$180.7B
Alcon (ALC)	$45.5B
Edwards Lifesciences (EW)	$40B
IQVIA Holdings (IQV)	$38.1B
IDEXX Laboratories (IDXX)	$33.9B
DexCom (DXCM)	$27.2B
Waters (WAT)	$23B
STERIS (STE)	$22.3B
SONOVA HOLDING (SONVY)	$22B
Hologic (HOLX)	$19.4B
Fresenius Medical Care AG KGaA (FMS)	$11.8B
Sysmex ADR (SSMXY)	$11.6B
Globus Medical (GMED)	$10.1B
Teleflex (TFX)	$9.6B
Penumbra (PEN)	$8.8B
Masimo (MASI)	$7.8B
Glaukos (GKOS)	$7.2B
PROCEPT BioRobotics (PRCT)	$5.1B
Integer Holdings (ITGR)	$4.2B
Inari Medical (NARI)	$2.9B
TransMedics (TMDX)	$2.9B
Veracyte (VCYT)	$2.7B
LivaNova (LIVN)	$2.7B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.2B
RxSight (RXST)	$1.9B
Integra LifeSciences Holdings (IART)	$1.9B
Alphatec Holdings (ATEC)	$1.2B